BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of €9.72 billion as of January 2, 2026. Its market cap has decreased by -18.87% in one year.

Market Cap

9.72B

Enterprise Value

8.98B

Revenue

2.64B

Ranking

n/a

PE Ratio

21.92

Stock Price

€50.42

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.72B, an increase of 2,184.70%. That is a compound annual growth rate of 12.55%.

Market Cap History

Date	Market Cap	% Change
Dec 31, 2025	9.72B	-19.63%
Dec 31, 2024	12.10B	-26.36%
Dec 29, 2023	16.43B	-8.70%
Dec 30, 2022	18.00B	26.18%
Dec 31, 2021	14.26B	9.60%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniCredit	110.47B
Intesa Sanpaolo	102.93B
Enel SpA	89.44B
Ferrari	56.50B
Assicurazioni Generali	54.29B
Eni S.p.A.	48.95B
Leonardo S.p.a.	28.34B
Poste Italiane	27.80B

Market Cap Rankings